SLC5A2 and type 2 diabetes mellitus: Regarding the drugs used to treat T2DM, some considerations are worth noting: women can have higher risk of hypoglycemia with sulfonylureas and different response to glitazones, related to kidney function and body composition.182 However, men can have higher response to weight loss induced by SGLT2 inhibitors, partially due to the difference in body fat distribution.